Multibic

Sodium Hydrogen Carbonate, the active ingredient in Multibic, is an electrolyte solution presented as a sterile injectable solution for intravenous and haemodialysis use. It helps correct metabolic acidosis and maintain electrolyte balance in patients undergoing renal replacement therapy.

GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Multibic is used as an intravenous electrolyte and buffering solution in renal replacement therapy. - Haemodialysis: provides bicarbonate buffering to correct metabolic acidosis during treatment. - Peritoneal dialysis: supplies calcium and magnesium to maintain mineral homeostasis. - Acute renal failure: assists in stabilising serum electrolytes while renal function recovers.

Multibic may be associated with several adverse reactions when administered intravenously.

Common Side Effects: - Hypotension: transient drop in blood pressure during infusion. - Mild nausea or vomiting: related to rapid electrolyte shifts. - Local irritation: redness or discomfort at the infusion site.

Serious or Rare Side Effects: - Hypercalcemia: elevated calcium levels causing cardiac arrhythmia. - Severe electrolyte imbalance: marked changes in serum magnesium or chloride leading to neuromuscular symptoms. - Anaphylactic reaction: rare hypersensitivity requiring immediate medical intervention.

When using Multibic, clinicians should observe several safety measures. - Monitor electrolytes: check serum calcium, magnesium, sodium and bicarbonate levels before and after infusion. - Assess cardiac function: observe ECG for arrhythmias, especially in patients with pre‑existing heart disease. - Adjust infusion rate: administer slowly to avoid rapid shifts in plasma osmolality. - Contraindications: avoid in patients with known hypersensitivity to any component. - Pregnancy and lactation: use only if the potential benefit justifies the risk. - Store at ambient temperature: keep below 25°C, protect from moisture and light, and retain in original sealed container.

Multibic can interact with other medications that influence electrolyte or acid‑base status.

Major Interactions (Avoid): - Calcium channel blockers: may exacerbate hypercalcemia. - Loop diuretics: increase risk of severe electrolyte depletion when combined.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may potentiate changes in potassium and bicarbonate levels. - Antacids containing magnesium or calcium: additive effect on serum concentrations. - Sodium‑containing IV fluids: risk of hypernatremia if volumes are not carefully balanced.